Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Arcese

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 1, 2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donorC Cerva, L Colagrossi, G Maffongelli, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)E Todisco, F Ciceri, C Boschini, et al.
Bone Marrow Transplantation|July 15, 2003
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remissionG Dini, M Grazia Valsecchi, C Micalizzi, et al.
Bone Marrow Transplantation|October 23, 1997
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationF van Rhee, R M Szydlo, J Hermans, et al.
Bone Marrow Transplantation|April 27, 1999
Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemiaW Arcese, C Guglielmi, A P Iori, et al.
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Bone Marrow Transplantation|January 12, 2016
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant NetworkA Tendas, L Cupelli, M R Mauroni, et al.
Bone Marrow Transplantation|April 20, 2004
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantationA P Iori, R Cerretti, L De Felice, et al.
Leukemia|April 18, 2015
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemiaA Ruggeri, M Labopin, G Sanz, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 1, 2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donorC Cerva, L Colagrossi, G Maffongelli, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)E Todisco, F Ciceri, C Boschini, et al.
Bone Marrow Transplantation|July 15, 2003
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remissionG Dini, M Grazia Valsecchi, C Micalizzi, et al.
Bone Marrow Transplantation|October 23, 1997
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationF van Rhee, R M Szydlo, J Hermans, et al.
Bone Marrow Transplantation|April 27, 1999
Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemiaW Arcese, C Guglielmi, A P Iori, et al.
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Bone Marrow Transplantation|January 12, 2016
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant NetworkA Tendas, L Cupelli, M R Mauroni, et al.
Bone Marrow Transplantation|April 20, 2004
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantationA P Iori, R Cerretti, L De Felice, et al.
Leukemia|April 18, 2015
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemiaA Ruggeri, M Labopin, G Sanz, et al.
Pageof 16